|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 342.00 EUR | +0.29% |
|
-7.94% | -4.34% |
| May. 11 | Virbac continues decline despite positive recommendation |  |
| Apr. 17 | Virbac: 2026 starts on strong footing |  |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Veterinary Drugs | ||||||||||
Companion Animals | 609M | 706M | 721M | 824M | 869M | |||||
Farm Animals | 426M | 478M | 493M | 537M | 575M | |||||
Pharmaceutical Contract Manufacturing Services | ||||||||||
Other Businesses | 28.8M | 31.8M | 33.2M | 36.3M | 20.3M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Europe | - | - | - | 571M | 610M | |||||
Total Assets | - | - | - | 565M | 794M | |||||
D&A | - | - | - | - | 26.49M | |||||
CAPEX | - | - | - | -49.09M | -64.33M | |||||
Net Income | - | - | - | 61.16M | 63.77M | |||||
Operating Income | - | - | - | 90.99M | 89.84M | |||||
Latin America | 167M | 197M | 214M | 222M | 223M | |||||
Total Assets | 205M | 272M | 280M | 272M | 262M | |||||
D&A | - | - | - | - | 7.76M | |||||
CAPEX | -3.17M | -4.21M | -4.24M | -5.36M | -4.23M | |||||
Net Income | 15.87M | 13.17M | 9.68M | 19.78M | 18.07M | |||||
Operating Income | 34.78M | 33.64M | 31.52M | 37.96M | 34.54M | |||||
North America | 124M | 162M | 165M | 182M | 200M | |||||
Total Assets | -132M | 231M | 220M | 249M | 209M | |||||
D&A | - | - | - | - | 7.44M | |||||
CAPEX | -7.63M | -9.7M | -5.46M | -11.12M | -8.64M | |||||
Net Income | -9.14M | -6.03M | -10.13M | 2.06M | -1.64M | |||||
Operating Income | -6.97M | -3.97M | -5.57M | 4.85M | 4.64M | |||||
India, Africa and Middle East ("IMEA") | - | - | - | 174M | 178M | |||||
Total Assets | - | - | - | 172M | 131M | |||||
D&A | - | - | - | - | 3.1M | |||||
CAPEX | - | - | - | -1.02M | -2.24M | |||||
Net Income | - | - | - | 40.04M | 41.32M | |||||
Operating Income | - | - | - | 52.13M | 54.68M | |||||
Far East Asia | - | - | - | 141M | 154M | |||||
Total Assets | - | - | - | 467M | 407M | |||||
D&A | - | - | - | - | 11.6M | |||||
CAPEX | - | - | - | -3.28M | -3.89M | |||||
Net Income | - | - | - | 2.75M | 9.4M | |||||
Operating Income | - | - | - | 15.46M | 17.83M | |||||
Pacific | 94.19M | 118M | 116M | 108M | 101M | |||||
Total Assets | 111M | 130M | 129M | 124M | 111M | |||||
D&A | - | - | - | - | 3.46M | |||||
CAPEX | -1.11M | -2.08M | -3.59M | -4.97M | -1.55M | |||||
Net Income | 17.66M | 24.36M | 26.9M | 19.5M | 19.98M | |||||
Operating Income | 26.24M | 35.74M | 39.16M | 30.43M | 28.13M | |||||
Africa & Middle East | 29.7M | 32.47M | 29.67M | - | - | |||||
Total Assets | 11.15M | 15.73M | 15.99M | - | - | |||||
CAPEX | -110K | -275K | -234K | - | - | |||||
Net Income | 3.24M | 2.98M | 2.55M | - | - | |||||
Operating Income | 4.72M | 4.3M | 3.48M | - | - | |||||
Europe (Excluding france) | 281M | 303M | 327M | - | - | |||||
Total Assets | 62.52M | 100M | 131M | - | - | |||||
CAPEX | -578K | -1.01M | -545K | - | - | |||||
Net Income | 16.41M | 21.76M | 24.07M | - | - | |||||
Operating Income | 22.88M | 28.85M | 32.4M | - | - | |||||
Asia | 184M | 213M | 204M | - | - | |||||
Total Assets | 186M | 244M | 293M | - | - | |||||
CAPEX | -8.01M | -3.67M | -2.94M | - | - | |||||
Net Income | 28.58M | 31.12M | 34.91M | - | - | |||||
Operating Income | 37.04M | 40.89M | 42.04M | - | - | |||||
France | 185M | 192M | 192M | - | - | |||||
Total Assets | 757M | 341M | 387M | - | - | |||||
CAPEX | -28.51M | -34.98M | -29.36M | - | - | |||||
Net Income | 40.55M | 34.61M | 33.32M | - | - | |||||
Operating Income | 54.48M | 47.12M | 45.12M | - | - |
- Stock Market
- Equities
- VIRP Stock
- Financials Virbac
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
